M de Zwart

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

S. Moro, K. Jacobson, A. IJzerman, 1998, Journal of medicinal chemistry.